Published 6th October 2021

MINIject’s data presented at European Ophthalmology Futures Forum, Virtual 2021

iSTAR Medical was selected for a presentation at the virtual European Ophthalmology Futures Forum this Thursday 7 October, where CEO Michel Vanbrabant will present competitive strengths for iSTAR Medical’s revolutionary MIGS device MINIjectTM.


Session: Company Presentations 3
Time: 18:20 – 19:20 CEST

The clinical data show consistently positive safety and efficacy outcomes in a larger patient population from ongoing trials.

The next generation MIGS made of anti-fibrotic STAR material has shown powerful and sustained performance as well as safety in clinical studies to-date, which is promising for very long-term results for the treatment of patients with open-angle glaucoma Vanbrabant commented.

Ophthalmology Futures Forums are clinician-driven innovation meetings in the ophthalmic healthcare sector. They cover all aspects of global innovation in ophthalmic devices, diagnostics and pharmaceuticals by connecting scientists, physicians, regulators, reimbursement specialists, corporate leaders, venture capitalists and other investors who support the advancement of eye care.

Share this entry
scroll to up
Sign up to receive company news alerts